Hand-Foot syndrome induced by sorafenib, a multitargeted tyrosine kinase inhibitor, in a patient with advanced renal cell carcinoma

Korean Journal of Pediatrics ◽

10.3345/kjp.2009.52.1.119 ◽

2009 ◽

Vol 52 (1) ◽

pp. 119

Author(s):

Seung Hyun Lee ◽

Sung Hun Noh ◽

Sun Young Kim ◽

Kyu Yun Jang ◽

Pyoung Han Hwang

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Kinase Inhibitor ◽

Advanced Renal Cell Carcinoma ◽

Hand Foot Syndrome ◽

Multitargeted Tyrosine Kinase Inhibitor

Download Full-text

Consolidative Renal Cell Carcinoma Metastatectomy for Partial Response After Multitargeted Tyrosine Kinase Inhibitor Therapy

Urology ◽

10.1016/j.urology.2007.03.044 ◽

2007 ◽

Vol 70 (1) ◽

pp. 178.e9-178.e11 ◽

Author(s):

Mischel G. Neill ◽

Alice C. Wei ◽

Michael A.S. Jewett

Keyword(s):

Renal Cell Carcinoma ◽

Partial Response ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Kinase Inhibitor ◽

Inhibitor Therapy ◽

Tyrosine Kinase Inhibitor Therapy ◽

Multitargeted Tyrosine Kinase Inhibitor

Download Full-text

Two cases of gastrointestinal perforation after radiotherapy in patients receiving tyrosine kinase inhibitor for advanced renal cell carcinoma

World Journal of Surgical Oncology ◽

10.1186/1477-7819-10-167 ◽

2012 ◽

Vol 10 (1) ◽

pp. 167 ◽

Author(s):

Takaaki Inoue ◽

Hidefumi Kinoshita ◽

Yoshihiro Komai ◽

Takashi Kawabata ◽

Gen Kawa ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Kinase Inhibitor ◽

Gastrointestinal Perforation ◽

Advanced Renal Cell Carcinoma

Download Full-text

Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma

Expert Opinion on Investigational Drugs ◽

10.1517/13543784.17.2.253 ◽

2008 ◽

Vol 17 (2) ◽

pp. 253-261 ◽

Author(s):

Guru Sonpavde ◽

Thomas E Hutson ◽

Cora N Sternberg

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Small Molecule ◽

Kinase Inhibitor ◽

Multitargeted Tyrosine Kinase Inhibitor

Download Full-text

Pazopanib: An Oral Multitargeted Tyrosine Kinase Inhibitor for Use in Renal Cell Carcinoma

Annals of Pharmacotherapy ◽

10.1345/aph.1m251 ◽

2010 ◽

Vol 44 (6) ◽

pp. 1054-1060 ◽

Author(s):

Kourtney D LaPlant ◽

Paige D Louzon

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Kinase Inhibitor ◽

Multitargeted Tyrosine Kinase Inhibitor

Download Full-text

Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?

Advances in Therapy ◽

10.1007/s12325-021-02007-y ◽

2022 ◽

Author(s):

Mário Fontes-Sousa ◽

Helena Magalhães ◽

Alicia Oliveira ◽

Filipa Carneiro ◽

Filipa Palma dos Reis ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Kinase Inhibitor ◽

Treatment Options ◽

Advanced Renal Cell Carcinoma

Download Full-text

Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: study based on experience at the Hospital Universitario Central de Asturias

Clinical & Translational Oncology ◽

10.1007/s12094-010-0554-0 ◽

2010 ◽

Vol 12 (8) ◽

pp. 562-567 ◽

Author(s):

Carolina Muriel ◽

Emilio Esteban ◽

Norberto Corral ◽

Paula J. Fonseca ◽

María Luque ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Kinase Inhibitor ◽

Advanced Renal Cell Carcinoma

Download Full-text

A Case of Metastatic Renal Cell Carcinoma to the Maxillary Sinus Treated with Tyrosine Kinase Inhibitor

Korean Journal of Otorhinolaryngology - Head and Neck Surgery ◽

10.3342/kjorl-hns.2012.55.11.717 ◽

2012 ◽

Vol 55 (11) ◽

pp. 717 ◽

Author(s):

Young Hyo Kim ◽

Jae Eun Kim ◽

Sungmin Park ◽

Tae Young Jang

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Maxillary Sinus ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitor

Download Full-text

Faculty Opinions recommendation of Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717979900.793471988 ◽

2013 ◽

Author(s):

Hendrik van Poppel ◽

Yuri Tolkach

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitor ◽

Patient Survival ◽

Cytoreductive Nephrectomy

Download Full-text

Pegilodecakin as monotherapy or in combination with anti‐PD ‐1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I study

International Journal of Cancer ◽

10.1002/ijc.33556 ◽

2021 ◽

Author(s):

Nizar M. Tannir ◽

Kyriakos P. Papadopoulos ◽

Deborah J. Wong ◽

Raid Aljumaily ◽

Annie Hung ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Phase I ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Phase I Study ◽

Kinase Inhibitor ◽

Heavily Pretreated ◽

Pretreated Patients

Download Full-text

Long-term outcomes of tyrosine kinase inhibitor discontinuation in patients with metastatic renal cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-015-2942-1 ◽

2015 ◽

Vol 77 (2) ◽

pp. 339-347 ◽

Author(s):

Dong-Hoe Koo ◽

Inkeun Park ◽

Jin-Hee Ahn ◽

Dae-Ho Lee ◽

Dalsan You ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitor ◽

Long Term Outcomes ◽

Tyrosine Kinase Inhibitor Discontinuation

Download Full-text